Business Context and Reporting Period
This Form 8-K was filed by Trovagene, Inc. (not Cardiff Oncology, Inc.) on June 29, 2015. The report covers a specific corporate event occurring on that date regarding the company's inclusion in major market indexes.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event notification and does not contain financial statements or performance metrics.
Material Changes
On June 29, 2015, Trovagene, Inc. announced its inclusion in the following indexes:
- Russell 3000
- Russell 2000 Small Cap
- Russell Global Indexes
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the announcement of index inclusion.
Investor Verification Checklist
- Verify the correct registrant name is Trovagene, Inc., not Cardiff Oncology, Inc.
- Confirm the effective date of inclusion in the Russell 3000, Russell 2000, and Russell Global Indexes.
- Review the attached press release (Exhibit 99.1) for any additional details on the index inclusion criteria.